1. Introduction {#sec1}
===============

Total hip arthroplasty (THA) infections occur in 0.5 to 3% of patients, and may account for a third of reoperations and require multidisciplinary management \[[@B1]--[@B3]\]. Bilateral infections remain sporadic without clear recommendations. The large study from the Société Française d\'Orthopédie-Traumatologie (SOFCOT) reported only 3 bilateral out of 691 THA infections and recommended a two-stage strategy, but no guideline was given for the antibiotic therapy in such situations \[[@B4]\]. This issue was not addressed in the document of the recent International Consensus Meeting on Prosthetic Joint Infections (ICMPJI) \[[@B5]\]. It is largely admitted that a microbiological documentation is essential to manage such chronic infections \[[@B3]--[@B5]\]. Choosing a one-stage approach with bilateral replacement in the same session requires intraoperative administration of antibiotics before correcting the second side which may lead to false negative bacterial cultures on the second side. \[[@B3]--[@B6]\]. Facing two cases of bilateral infection we made the choice of one-stage strategy and we started probabilistic antibiotics intraoperatively for the first side before the change of the second side. We found it interesting to study these two cases to evaluate the influence of antibiotics on the culture of intraoperative samples and so to argument for prophylactic antibiotics during revision of infected THA.

2. Observation {#sec2}
==============

The first case was a sixty-year-old male, with an American Society of Anesthesiology (ASA) score of 2 and history of bilateral arthroplasty in 2009 and 2010 done at another institution. He was refereed to our center in 2011 for bilateral hip pain and was suspected of presenting chronic infection, because of radiological signs of intense femoral periosteal reaction ([Figure 1(a)](#fig1){ref-type="fig"}). Joint aspiration confirmed the diagnosis, identifying*Staphylococcus caprae* in both hips. The patient underwent a bilateral change in one stage with the administration of broad-spectrum empiric antibiotic therapy as soon as surgical samples were taken on the first side. Replacement of the second side was conducted with the same protocol. Microbiological cultures of both hips were positive with the same bacteria (*Staphylococcus caprae* sensitive to methicillin) found on four samples out of six, on standard and Rosenow\'s growth medium enriched cultures \[[@B7]\] ([Table 1](#tab1){ref-type="table"}).

The second case was a sixty-year-old female, with an ASA score of 2 and history of bilateral arthroplasty in 2006 and 2009, who consulted in 2012 for left hip pain associated with systemic inflammatory reaction ([Table 1](#tab1){ref-type="table"}). Microbiological cultures of the left hip liquid aspiration were positive with methicillin-sensitive*Staphylococcus aureus* (MSSA). Three weeks later, right hip pain occurred that justified a joint aspiration from the hip in which the same MSSA strain according to the antibiotype was identified. The patient underwent bilateral hip change in one stage according to same surgical and antibiotic therapy protocols as the first case. Cultures of the two hips were positive with the same bacteria (MSSA) on four samples out of six, on standard and Rosenow\'s growth medium enriched cultures \[[@B7]\].

The pathogens identified during hip aspiration were sensitive to the probabilistic antibiotics. Both cases received the same antibiotic treatment adapted to their antibiograms (rifampicin + levofloxacin) introduced on day 5 for five days intravenously and then for three months per os regimen. At the end of a three-year (case one) and two-year (case two) follow-up, the functional Oxford score \[[@B8]\] was, respectively, 12/60 and 18/60, their CRP was normal, and periosteal reaction had dropped for case one ([Figure 1(b)](#fig1){ref-type="fig"}).

3. Discussion {#sec3}
=============

Both cases suggest that it seems possible, with a satisfactory microbiological documentation and therefore culture-guided appropriate antibiotic therapy, to perform bilateral one-stage replacement of infected THA. Former studies were in favor of a two-stage revision to manage bilateral infected hip arthroplasties \[[@B4]\], but repeated surgery and an incapacity period due to two-stage replacement led us to prefer the option of one-stage surgery \[[@B3], [@B5], [@B6]\].

In the two cases presented above, there are some practical problems. Firstly, the one-stage revision option implies potential surgical risks. However, our patients had low morbidity with an ASA score of 2 and our surgery protocol was strict (change of all prosthesis components and intensive debridement of the surgical site). One-stage strategy allows sterilizing all septic sites and reduces cost (a single hospitalization and antibiotics therapy, a shorter nonworking period) and faster rehabilitation. Secondly, we believe there is a risk of contamination of the nonreplaced side, when the replacement is unilateral. Thirdly, the probabilistic antibiotic therapy could have resulted in false negative culture of the second hip, though it was not reported in our cases. The two cases of the present study advocate the use of antibiotic prophylaxis in case of THA revision for infection \[[@B6], [@B9]\]. It is however difficult to definitely conclude on this last point as the microbiological documentation is of paramount importance in the management of prosthetic joint infections \[[@B5], [@B6], [@B9]\].
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![(a) Preoperative AP view case 1 showing typical features of intense femoral periosteal reaction suggesting pain was related to infection. (b) Case  1 AP view at 3 years of follow-up showing regression of periosteal reaction.](CRIOR2016-3621749.001){#fig1}

###### 

Demographic, microbiological, and therapeutic data.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                        Case  1                                                                    Case  2                                            
  ----------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------- ------------------------------------- ------------ ------------
  Indication for THA                                                                                    Primary osteoarthritis                                                                                                        

  ASA score                                                                                             2                                                                          2                                                  

  CRP level at diagnosis (*N* \< 5 mg/L)                                                                18 mg/L                                                                    81 mg/L                                            

  White blood cells count (*N* = 4000--10000/mm^3^)                                                     11700/mm^3^                                                                12500/mm^3^                                        

  Neutrophil polynuclear cells count (*N* = 2000--8000/mm^3^)                                           9360/mm^3^                                                                 9850/mm^3^                                         

  Date of joint aspiration                                                                              02/11/2011                                                                 02/11/2011                            02/07/2012   14/07/2012

  Bacteria at culture                                                                                     *Staphylococcus caprae* sensitive to  methicillin (coagulase negative)    Methicillin-sensitive\                            
                                                                                                                                                                                   *Staphylococcus aureus* (MSSA)                     

  Date of 1-stage bilateral revision                                                                    21/11/2011                                                                 06/08/2012                                         

  Delay from probabilistic ATB to sample collection in the second hip                                   180 minutes                                                                180 minutes                                        

  Probabilistic ATB                                                                                     Cefepime + daptomycin                                                      Cefotaxime + vancomycin                            

  Culture-guided ATB debuted intravenously on day 5 for 5 days and then switched to oral for 10 weeks   Rifampicin + levofloxacin                                                  Rifampicin + levofloxacin                          

  Positivity of culture samples on the second side                                                       Same bacteria\                                                             Same bacteria\                                    
                                                                                                        4 out of 6 samples\                                                        4 out of 6 samples\                                
                                                                                                        (3 Rosenow\'s broth and 1 standard)                                        (2 Rosenow\'s broth and 2 standard)                

  CRP at the time of withdrawal of antibiotic therapy (*N* \< 5 mg/L)                                   5 mg/L                                                                     3 mg/L                                             

  Intraoperative bleeding                                                                               1200 cc                                                                    1600 cc                                            

  Posttreatment follow-up duration                                                                      36 months                                                                  24 months                                          
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ATB: antibiotics therapy; CRP: C-reactive protein.
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